A

Adline Chem Lab Ltd

ADLINE
Market snapshot · 2026-08-12 21:16 UTC

13.70

₹0.00 (+0.00%)

MARKET CAP

₹8.01 Cr

STOCK P/E

52W HIGH

₹17.95

52W LOW

₹7.60

BOOK VALUE

EPS

ROE

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

1,500

P/B RATIO

PEG RATIO

Sector

Healthcare

Themes

Drug Manufacturers - Specialty & Generic
₹17.95₹15.36₹12.77₹10.19₹7.60VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

Historical valuation metrics are unavailable for this ticker right now.

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrMar 2026

Latest net profit

₹-0.09 CrMar 2026

Latest EPS

₹-0.15Mar 2026

Free cash flow

₹-0.16 CrMar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-0.09 Cr0.00 Cr0.09 Cr0.18 Cr0.27 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr₹-0₹0₹0₹0₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherOtheradjustmentsNet Profit-0.14 Cr-0.10 Cr-0.07 Cr-0.04 Cr0.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-2.00 Cr0.00 Cr2.00 Cr4.00 Cr6.00 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +0.000.000.000.000.000.000.000.000.000.000.000.000.00
Expenses +0.080.080.030.000.070.100.070.100.060.030.050.030.08
Operating Profit-0.08-0.08-0.030.00-0.07-0.10-0.07-0.10-0.06-0.03-0.05-0.03-0.08
OPM %
Other Income +0.070.000.000.000.030.000.000.000.250.000.000.000.01
Interest0.000.000.030.030.000.030.030.030.030.030.030.040.04
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-0.01-0.08-0.06-0.03-0.04-0.13-0.10-0.130.16-0.06-0.08-0.07-0.11
Tax %0.00%0.00%-16.67%-33.33%0.00%-7.69%-10.00%-7.69%-31.25%-16.67%-12.50%-14.29%-9.09%
Net Profit +-0.01-0.08-0.05-0.02-0.04-0.13-0.09-0.120.21-0.05-0.07-0.06-0.09
EPS in Rs-0.02-0.14-0.09-0.03-0.07-0.22-0.15-0.210.36-0.09-0.12-0.10-0.15
Raw PDF
YOY Sales Growth %-100.00%
Other income normal0.070.000.000.000.030.000.000.000.250.000.000.000.01
Profit excl Excep-0-0-0-0-0-0-0-00-0-0-0-0
Profit for PE-0-0-0-0-0-0-0-00-0-0-0-0
Profit for EPS-0-0-0-0-0-0-0-00-0-0-0-0
YOY Profit Growth %-103%20%-120%0%-300%-62%-80%-500%625%62%22%50%-143%

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +29.61%29.61%25.85%25.85%25.85%
Public +70.39%70.38%74.15%74.15%74.14%
Others0.01%0.01%
Jun 2026
Promoters +
Public +
Others

Events Timeline

Board Meeting Intimation for For Considering And Approving Un-Audited Standalone Financial Results For The Quarter Ended On 30.06.2026.

Aug 10, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 15, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 29, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Resignation of Director

Jun 12, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

May 30, 2026PDFCompany Reports Open